Table 3: Summary of patents filed for MSCs used for treating ocular disorders.

No.	Cell Type	Patent No.	Disease	Summary	Trial Status	Route of Administration	Ref.
1	MSCs	US20060280729A1	Brain trauma, AMD, RP, optic nerve trauma, glaucoma etc.	Approach for treating patients by administration of pharmaceutical compositions of mesenchymal stem cells that are characterized by the presence or absence of surface markers wherein the cells help survival in situ but do not have similar structure as photoreceptor cells and do not express markers specific to such cells.	Pre-clinical	Surface of the eye or interior of the eye using a cannula or device, implantation using scaffolds/extracellular matrix containing cells	[44]